Shenxin Lu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning.
Journal: Journal of hepatocellular carcinoma
Published: March 05, 2025
Increased CAPG inhibits ferroptosis to drive tumor proliferation and sorafenib resistance in hepatocellular carcinoma via the WDR74-p53-SLC7A11 pathway.
Journal: International journal of biological sciences
Published: February 02, 2025
Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial.
Journal: Expert review of gastroenterology & hepatology
Published: January 18, 2024
Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.
Journal: Cellular and molecular gastroenterology and hepatology
Published: April 07, 2022
Predicting Disease-Specific Survival for Patients With Primary Cholangiocarcinoma Undergoing Curative Resection by Using a Decision Tree Model.
Journal: Frontiers in oncology
Published: November 29, 2021
First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
Journal: Frontiers in oncology
Published: September 06, 2021
The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
Journal: Disease markers
Published: September 03, 2021
An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Journal: Combinatorial chemistry & high throughput screening
Published: August 24, 2021
The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.
Journal: The International journal of biological markers
Published: August 10, 2021
Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
Journal: Annals of translational medicine
Published: March 12, 2021
Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study.
Journal: BioMed research international
Published: March 22, 2020
Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma.
Journal: Journal of Cancer
Published: March 04, 2020
Last Updated: 09/26/2026